{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:42Z","timestamp":1786984362085,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.amjmed.2020.11.024","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T10:13:25Z","timestamp":1608804805000},"page":"e366-e373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oral Anticoagulation Use in High-Risk Patients Is Improved by Elimination of False-Positive and Inactive Atrial Fibrillation Cases"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8196-4554","authenticated-orcid":false,"given":"Gerald V.","family":"Naccarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ruzieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-7870","authenticated-orcid":false,"given":"Deborah L.","family":"Wolbrette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-9956","authenticated-orcid":false,"given":"Mauricio","family":"Sendra-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"van Harskamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-9993","authenticated-orcid":false,"given":"Gregory","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0678-2504","authenticated-orcid":false,"given":"Nathan","family":"McConkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-7027","authenticated-orcid":false,"given":"Stephen","family":"Wasemiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovan","family":"Plamenac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frendy D.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9733-8806","authenticated-orcid":false,"given":"Thomas W.","family":"Abendroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0001","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.amjmed.2020.11.024_bib0002","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States: is it just due to the population aging?","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0003","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.amjmed.2020.11.024_bib0004","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.jacc.2019.10.040","article-title":"Ischemic stroke risk in patient with nonvalvular atrial fibrillation JACC Review topic of the week","volume":"74","author":"Alkhouli","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.amjmed.2020.11.024_bib0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation patients using a novel risk factor approach: The Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.amjmed.2020.11.024_bib0006","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.amjcard.2012.01.371","article-title":"CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation\/atrial flutter patients","volume":"109","author":"Naccarelli","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.amjmed.2020.11.024_bib0007","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation study. Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjmed.2020.11.024_bib0008","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2020.11.024_bib0009","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.amjmed.2020.11.024_bib0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"15","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.amjmed.2020.11.024_bib0011","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.amjmed.2020.11.024_bib0012","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2020.11.024_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0014","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.amjcard.2009.11.047","article-title":"Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry)","volume":"105","author":"Kowey","year":"2010","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.amjmed.2020.11.024_bib0015","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2020.11.024_bib0016","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjcard.2005.09.086","article-title":"Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry","volume":"97","author":"Reynolds","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.11.024_bib0017","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE Registry","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjmed.2020.11.024_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2018.10.004","article-title":"Stroke prevention in atrial fibrillation: Closing the gap","volume":"210","author":"Pokorney","year":"2019","journal-title":"Am Heart J"},{"issue":"20","key":"10.1016\/j.amjmed.2020.11.024_bib0019","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.jacc.2017.03.540","article-title":"Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation","volume":"69","author":"Marzec","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.11.024_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.160.1.41","article-title":"Why do patients with atrial fibrillation not receive warfarin?","volume":"160","author":"Bungard","year":"2000","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2020.11.024_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2014.09.014","article-title":"Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke","volume":"169","author":"Navar-Boggan","year":"2015","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.amjmed.2020.11.024_bib0022","first-page":"1561","article-title":"Identifying patients with atrial fibrillation in administrative data","volume":"32","author":"Tu","year":"2016","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.amjmed.2020.11.024_bib0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjcard.2015.10.031","article-title":"A simple and portable algorithm for identifying atrial fibrillation in the electronic medical record","volume":"117","author":"Khurshid","year":"2016","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.amjmed.2020.11.024_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014527","article-title":"Impact of different electronic cohort definitions to identify patients with atrial fibrillation from the electronic medical record","volume":"9","author":"Shah","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2020.11.024_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pds.2317","article-title":"A systematic review of validated methods for identifying atrial fibrillation using administrative data","volume":"21","author":"Jensen","year":"2012","journal-title":"Pharmacoepidiol Drug Saf"},{"key":"10.1016\/j.amjmed.2020.11.024_bib0026","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-017-0018-x","article-title":"The effects of misclassification in routine healthcare databases on the accuracy of prognostic prediction models: a case study of the CHA2DS2\u2013VASc score in atrial fibrillation","volume":"1","author":"Van Doom","year":"2017","journal-title":"Diagn Progn Res"},{"issue":"3","key":"10.1016\/j.amjmed.2020.11.024_bib0027","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjmed.2020.11.024_bib0028","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2017.08.011","article-title":"International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF and ORBIT AF-II Registries","volume":"194","author":"Steinberg","year":"2017","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.amjmed.2020.11.024_bib0029","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jacep.2019.07.011","article-title":"Ischemic and bleeding outcomes in patients with atrial fibrillation and contraindications to oral anticoagulation","volume":"5","author":"Steinberg","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.11.024_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvw022","article-title":"Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2VASc score","volume":"3","author":"Overvad","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"6","key":"10.1016\/j.amjmed.2020.11.024_bib0031","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.113.004498","article-title":"Shared decision making in atrial fibrillation. Where we are and where we should be going","volume":"129","author":"Seaburg","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.amjmed.2020.11.024_bib0032","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/CIRCULATIONAHA.117.031354","article-title":"Prognostic significance of nuisance bleeding in anticoagulated patients with atrial fibrillation","volume":"138","author":"O'Brien","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0033","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donze","year":"2012","journal-title":"Am J Med"},{"issue":"9689","key":"10.1016\/j.amjmed.2020.11.024_bib0034","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2020.11.024_bib0035","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2018.06.065","article-title":"Outcomes among patients with atrial fibrillation and appropriate anticoagulation control","volume":"72","author":"Bonde","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0036","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamacardio.2019.1960","article-title":"Association between warfarin control metrics and atrial fibrillation outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation","volume":"4","author":"Pokorney","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.amjmed.2020.11.024_bib0037","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.112.142158","article-title":"Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention of atrial fibrillation","volume":"127","author":"Wallentin","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2020.11.024_bib0038","first-page":"912","article-title":"Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits","volume":"2017","author":"Horskey","year":"2017","journal-title":"AMIA Annu Symp Proc"},{"issue":"8 suppl","key":"10.1016\/j.amjmed.2020.11.024_bib0039","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/MLR.0b013e31829b1d48","article-title":"Challenges in using electronic health record data for CER. Experience of 4 learning organizations and solutions applied","volume":"51","author":"Bayley","year":"2013","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.amjmed.2020.11.024_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCOUTCOMES.113.000371","article-title":"Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation","volume":"8","author":"Thigpen","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"10.1016\/j.amjmed.2020.11.024_bib0041","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jamacardio.2016.3236","article-title":"Comparison of approaches for heart failure case identification from electronic health record data","volume":"1","author":"Blecker","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"13","key":"10.1016\/j.amjmed.2020.11.024_bib0042","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/CIRCULATIONAHA.117.027436","article-title":"Validity of cardiovascular data from electronic sources. The Multi-Ethnic study of atherosclerosis and HealthLNK","volume":"136","author":"Ahmad","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjmed.2020.11.024_bib0043","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/CIRCULATIONAHA.118.035909","article-title":"Adherence to guideline-directed stroke prevention therapy for atrial fibrillation is achievable. First results from Get With The Guidelines-Atrial-Fibrillation (GWTG-AFIB)","volume":"139","author":"Piccini","year":"2019","journal-title":"Circulation"},{"issue":"10104","key":"10.1016\/j.amjmed.2020.11.024_bib0044","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.amjmed.2020.11.024_bib0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/eurheartj\/ehz385","article-title":"Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT)","volume":"41","author":"Piazza","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0046","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.19102\/icrm.2017.080803","article-title":"The use of electronic personal health records to improve medication adherence and patient engagement: A randomized study of non-valvular atrial fibrillation patients","volume":"8","author":"Chen","year":"2017","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.amjmed.2020.11.024_bib0047","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1745-6215-14-385","article-title":"Automated risk assessment for stroke in atrial fibrillation (AURAS-AF) \u2013 an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomized trial","volume":"14","author":"Holt","year":"2013","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.amjmed.2020.11.024_bib0048","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamacardio.2016.3366","article-title":"Evaluation of a prediction model for the development of atrial fibrillation in a repository of electronic medical records","volume":"1","author":"Kolek","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjmed.2020.11.024_bib0049","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.19102\/icrm.2016.070802","article-title":"Electronic medical record (EMR)-derived appropriate inpatient risk stratification and anticoagulation treatment of atrial fibrillation at a large academic medical center: opportunities for EMR-based clinical decision-making support tools","volume":"7","author":"Lively","year":"2016","journal-title":"J Innov Card Rhythm Manag"},{"issue":"2","key":"10.1016\/j.amjmed.2020.11.024_bib0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jamia\/ocw082","article-title":"Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention","volume":"24","author":"Wang","year":"2017","journal-title":"J Am Med Inform Assoc"},{"issue":"11","key":"10.1016\/j.amjmed.2020.11.024_bib0051","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jacep.2019.07.016","article-title":"Development and validation of a prediction model for atrial fibrillation using electronic health records","volume":"5","author":"Hulme","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.amjmed.2020.11.024_bib0052","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.amjcard.2017.07.002","article-title":"Sex and gender differences in thromboprophylactic treatment of patients with atrial fibrillation after the introduction of non-vitamin K oral anticoagulants","volume":"120","author":"Loikas","year":"2017","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2020.11.024_bib0053","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamacardio.2016.0529","article-title":"Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry","volume":"1","author":"Piccini","year":"2016","journal-title":"JAMA Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320311256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320311256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:29:23Z","timestamp":1762079363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934320311256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0002934320311256"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.11.024","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Anticoagulation Use in High-Risk Patients Is Improved by Elimination of False-Positive and Inactive Atrial Fibrillation Cases","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}